At a glance
- Originator Pulmocide
- Class Amides; Antivirals; Benzazepines; Pyridines; Small molecules; Spiro compounds; Thiophenes
- Mechanism of Action RNA replicase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Respiratory syncytial virus infections
Most Recent Events
- 27 Oct 2020 Discontinued - Phase-II for Respiratory syncytial virus infections in United Kingdom (Inhalation) (Pulmocide's pipeline, October 2020)
- 01 May 2019 Pulmocide terminates the phase II TreatRSV1 trial in Respiratory syncytial virus infections in United Kingdom (Inhalation) (NCT03715023)
- 25 Jan 2019 Chemical structure information added